Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mize Lu"'
Publikováno v:
Molecules, Vol 21, Iss 3, p 322 (2016)
Background: Hepatic iron overload is common in patients who have undergone hematopoietic cell transplantation (HCT) and may predispose to peri- and post-HCT toxicity. To better reveal more molecules that might be involved in iron overload-induced liv
Externí odkaz:
https://doaj.org/article/1b5e8de6141c426dac5b1be2e0fe46b9
Publikováno v:
Biochemical and Biophysical Research Communications. 470:324-330
Mammalian target of rapamycin (mTOR) as a potential drug target for treatment of acute myeloid leukemia (AML). Here, we investigated the potential anti-leukemic activity by WYE-687, a potent mTOR kinase inhibitor. We demonstrated that WYE-687 potentl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79f784b73f6ef5e35106fe49034ef6f6
https://doi.org/10.1016/j.bbrc.2016.01.054
https://doi.org/10.1016/j.bbrc.2016.01.054
Publikováno v:
Molecules
Molecules, Vol 21, Iss 3, p 322 (2016)
Molecules; Volume 21; Issue 3; Pages: 322
Molecules, Vol 21, Iss 3, p 322 (2016)
Molecules; Volume 21; Issue 3; Pages: 322
Background: Hepatic iron overload is common in patients who have undergone hematopoietic cell transplantation (HCT) and may predispose to peri- and post-HCT toxicity. To better reveal more molecules that might be involved in iron overload-induced liv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::107ea6e374d91b6f443b188d9d4b1fea
http://europepmc.org/articles/PMC6272870
http://europepmc.org/articles/PMC6272870
Autor:
Xifeng Qian, Xin Zhou, Jun Xia, Hong-Li Sun, Feng Chen, Yuanqiang Jiang, Mize Lu, Heng Chen, Yun-Feng Shen, Jingjue Mao, Yun Zhuang, Guohua Yang, Chao Sun, Hongfeng Guo
Publikováno v:
American Journal of Hematology. 85:499-501
Bortezomib has proven to be active in patients with multiple myeloma (MM), including elderly patients. The aim of this study was to evaluate the efficacy and toxicity of bortezomib in combination with intermediate-dose dexamethasone (Dex) and thalido
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf87c72932a2dc1572f46dd8967424b4
https://doi.org/10.1002/ajh.21734
https://doi.org/10.1002/ajh.21734
JAK2 V617F, MPL W515L and JAK2 exon 12 mutations are novel acquired mutations that induce constitutive cytokine-independent activation of the JAK-STAT pathway in myeloproliferative disorders (MPD). The discovery of these mutations provides novel mech
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a12a11d403e52eff0b015742e967d4d
https://europepmc.org/articles/PMC3555257/
https://europepmc.org/articles/PMC3555257/
Publikováno v:
Blood. 108:4918-4918
Myeloproliferative Diseases (MPD) are a spectrum of pathogenetically related disorders of varying clinical manifestations, characterized by neoplastic expansion of relatively mature granulocyte, erythroid, megakaryocyte, or monocyte and eosinocyte li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d4777792fbe38e3fff8b0170c923f81
https://doi.org/10.1182/blood.v108.11.4918.4918
https://doi.org/10.1182/blood.v108.11.4918.4918